Logotype for Alignment Healthcare

Alignment Healthcare (ALHC) Q2 2026 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Alignment Healthcare

Q2 2026 earnings summary

30 Jul, 2026

Executive summary

  • Health plan membership grew 31.5% year-over-year to 294,100 as of June 30, 2026, driving a 31.6% increase in quarterly revenues to $1.34 billion and a 32.4% increase in six-month revenues to $2.57 billion.

  • Net income for Q2 2026 was $36.6 million, up from $15.7 million in Q2 2025, with adjusted EBITDA rising 48.4% to $68.1 million (5.1% margin).

  • The medical benefits ratio (MBR) improved to 86.3% from 86.7% year-over-year, reflecting effective cost management.

  • Investments in AI, clinical operations, and automation are supporting both near-term efficiency and long-term scalability.

  • Embedded gross profit potential within current membership has grown to $880 million, with 2026 full-year guidance midpoint at $640 million adjusted gross profit.

Financial highlights

  • Adjusted gross profit for Q2 2026 was $182.9 million, up 35.3% year-over-year, with an adjusted MBR of 86.3%.

  • Adjusted SG&A was $115 million (8.6% of revenue), improving 20 basis points year-over-year.

  • Operating cash flow for the first half was $111.4 million, up from $45.7 million in the prior year; liquidity at quarter-end was $701.7 million in cash and equivalents.

  • Funded leverage ratio improved to 2.2x trailing 12-month EBITDA.

  • Quarterly income from operations increased 85.1% to $42.1 million; net income margin rose to 2.7% of revenue.

Outlook and guidance

  • Full-year 2026 guidance: membership 298,000–301,000; revenue $5.20–$5.23 billion; adjusted gross profit $630–$650 million; Adjusted EBITDA $145–$163 million.

  • Q3 2026 guidance: membership 295,500–297,500; revenue $1.30–$1.32 billion; adjusted gross profit $148–$158 million; Adjusted EBITDA $20–$30 million.

  • Raised full-year revenue and profitability guidance following strong first half; expect 30% of full-year Adjusted EBITDA in the second half.

  • Management expects continued investment in technology, market expansion, and product innovation to drive future growth.

  • Cash flows and liquid assets are expected to be sufficient to fund operations and capital needs for at least the next 12 months.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more